{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:34:20Z","timestamp":1780367660195,"version":"3.54.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T00:00:00Z","timestamp":1451347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Papillomavirus Research"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.pvr.2016.05.001","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T12:45:25Z","timestamp":1463489125000},"page":"106-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Monitoring the impact of HPV vaccine in males\u2014Considerations and challenges"],"prefix":"10.1016","volume":"2","author":[{"given":"Julia M.L.","family":"Brotherton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna R.","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri E.","family":"Markowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen F.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina S.","family":"Ogilvie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pvr.2016.05.001_bib1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens--Part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.pvr.2016.05.001_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.annepidem.2009.01.023","article-title":"The epidemiology behind the HPV vaccine discovery","volume":"19","author":"Koutsky","year":"2009","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.pvr.2016.05.001_bib3","first-page":"1","article-title":"HPV vaccination: current global status","author":"Brotherton","year":"2015","journal-title":"Curr. Obstet. Gynecol. Rep."},{"issue":"4","key":"10.1016\/j.pvr.2016.05.001_bib4","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.25396","article-title":"Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication","volume":"128","author":"Li","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.pvr.2016.05.001_bib5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women","volume":"372","author":"Joura","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pvr.2016.05.001_bib6","unstructured":"World Health Organization, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol 90, Human Papillomaviruses. Available at: \u3008http:\/\/monographs.iarc.fr\/ENG\/Monographs\/vol90\/\u3009, (accessed 01.09.15)."},{"issue":"11","key":"10.1016\/j.pvr.2016.05.001_bib7","first-page":"300","article-title":"Use of 9-valent human papillomavirus (HPV) vaccine: updated hpv vaccination recommendations of the advisory committee on immunization practices","volume":"64","author":"Petrosky","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.pvr.2016.05.001_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2015.06.088","article-title":"Immunogenicity and safety of the 9-valent HPV vaccine in men","author":"Castellsagu\u00e9","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.pvr.2016.05.001_bib9","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1542\/peds.2014-3745","article-title":"Immunogenicity and safety of a 9-valent HPV vaccine","volume":"136","author":"Van Damme","year":"2015","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.pvr.2016.05.001_bib10","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1473-3099(12)70031-2","article-title":"Population-wide vaccination against human papillomavirus in adolescent boys: Australia as a case study","volume":"12","author":"Georgousakis","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pvr.2016.05.001_bib11","unstructured":"Orlandi L. Austria to vaccinate boys and girls against HPV. Press Release, West 18\/09\/2013. Available at: \u3008http:\/\/www.west-info.eu\/austria-to-vaccinate-boys-and-girls-against-hpv\/\u3009, (accessed 31.08.15)."},{"issue":"2","key":"10.1016\/j.pvr.2016.05.001_bib12","doi-asserted-by":"crossref","first-page":"E197","DOI":"10.33321\/cdi.2015.39.17","article-title":"Interim estimates of male human papillomavirus vaccination coverage in the school-based program in Australia","volume":"39","author":"Brotherton","year":"2015","journal-title":"Commun. Dis. Intell. Q. Rep."},{"key":"10.1016\/j.pvr.2016.05.001_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiv342","article-title":"Reduction in HPV vaccine type prevalence among young women screened for cervical cancer in an integrated health care delivery system, United States 2007, 2012\u20132013","author":"Dunne","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.pvr.2016.05.001_bib14","first-page":"43","article-title":"Human papillomavirus vaccination for boys","volume":"61","author":"Quinn","year":"2015","journal-title":"Can. Fam. Physician"},{"issue":"Suppl. 5","key":"10.1016\/j.pvr.2016.05.001_bib15","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases","volume":"30","author":"Forman","year":"2012","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.pvr.2016.05.001_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.27650","article-title":"EUROGIN 2011 Roadmap on prevention and treatment of HPV-related disease","volume":"131","author":"Arbyn","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.pvr.2016.05.001_bib17","unstructured":"K.A. Workowski, G.A. Bolan, Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommendations and reports: Morbidity and Mortality Weekly Report Recommendations and reports\/Centers for Disease Control, 2015, 64(Rr-03), 1\u2013137."},{"issue":"6","key":"10.1016\/j.pvr.2016.05.001_bib18","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1071\/SH12116","article-title":"Time for a strategic research response to anal cancer","volume":"9","author":"Grulich","year":"2012","journal-title":"Sex. Health"},{"issue":"4","key":"10.1016\/j.pvr.2016.05.001_bib19","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.jadohealth.2010.01.010","article-title":"Human papillomavirus-related disease in men: not just a women\u2019s issue","volume":"46","author":"Palefsky","year":"2010","journal-title":"J. Adolesc. Health"},{"issue":"Suppl. 5","key":"10.1016\/j.pvr.2016.05.001_bib20","doi-asserted-by":"crossref","first-page":"F168","DOI":"10.1016\/j.vaccine.2012.06.045","article-title":"Human papillomavirus, human immunodeficiency virus and immunosuppression","volume":"30","author":"Denny","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.pvr.2016.05.001_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2334-13-39","article-title":"Systematic review of the incidence and prevalence of genital warts","volume":"13","author":"Patel","year":"2013","journal-title":"BMC Infect. Dis."},{"issue":"5","key":"10.1016\/j.pvr.2016.05.001_bib22","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.vaccine.2010.10.018","article-title":"Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries","volume":"29","author":"Wong","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.pvr.2016.05.001_bib23","unstructured":"Human papillomavirus vaccines: WHO position paper, October 2014. Wkly Epidemiol Rec, 89(43): 465-492. (Available at): http:\/\/www.who.int\/wer\/2014\/wer8943.pdf Accessed 01\/09\/2015."},{"issue":"30","key":"10.1016\/j.pvr.2016.05.001_bib24","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1016\/j.vaccine.2010.02.019","article-title":"Post-licensure monitoring of HPV vaccine in the United States","volume":"28","author":"Markowitz","year":"2010","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.pvr.2016.05.001_bib25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jadohealth.2013.09.018","article-title":"Population impact of HPV vaccines: summary of early evidence","volume":"53","author":"Hariri","year":"2013","journal-title":"J. Adolesc. Health"},{"issue":"3","key":"10.1016\/j.pvr.2016.05.001_bib26","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1071\/SH09137","article-title":"Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy","volume":"7","author":"Brotherton","year":"2010","journal-title":"Sex. Health"},{"issue":"3","key":"10.1016\/j.pvr.2016.05.001_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djt460","article-title":"Early impact of human papillomavirus vaccination on cervical neoplasia--nationwide follow-up of young Danish women","volume":"106","author":"Baldur-Felskov","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"issue":"9","key":"10.1016\/j.pvr.2016.05.001_bib28","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/bjc.2014.479","article-title":"Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland","volume":"111","author":"Pollock","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.pvr.2016.05.001_bib29","first-page":"37","article-title":"The Manitoba human papillomavirus vaccine surveillance and evaluation system","volume":"21","author":"Kliewer","year":"2010","journal-title":"Health Rep."},{"key":"10.1016\/j.pvr.2016.05.001_bib30","unstructured":"WHO, Report of the meeting on HPV Vaccine Coverage and Impact Monitoring, 16\u201317 November 2009, Geneva, Switzerland, 2009."},{"issue":"30","key":"10.1016\/j.pvr.2016.05.001_bib31","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1016\/j.vaccine.2010.04.070","article-title":"A summary of the post-licensure surveillance initiatives for GARDASIL\/SILGARD","volume":"28","author":"Bonanni","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.pvr.2016.05.001_bib32","doi-asserted-by":"crossref","first-page":"f2032","DOI":"10.1136\/bmj.f2032","article-title":"Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data","volume":"346","author":"Ali","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.pvr.2016.05.001_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/infdis\/jiu370","article-title":"Fall in genital warts diagnoses in the general and Indigenous Australian population following implementation of a national human papillomavirus vaccination program: analysis of routinely collected national hospital data","volume":"211","author":"Smith","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.pvr.2016.05.001_bib34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(14)71073-4","article-title":"Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis","volume":"15","author":"Drolet","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pvr.2016.05.001_bib35","unstructured":"National Health and Nutrition Examination Survey, Centers for Disease Control and Prevention. Available at: \u3008http:\/\/www.cdc.gov\/nchs\/nhanes.htm\u3009, (accessed 31.08.15)."},{"issue":"9907","key":"10.1016\/j.pvr.2016.05.001_bib36","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(13)61947-9","article-title":"Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (NATSALl)","volume":"382","author":"Sonnenberg","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.pvr.2016.05.001_bib37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.vaccine.2014.10.045","article-title":"Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program","volume":"33","author":"Osborne","year":"2015","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.pvr.2016.05.001_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.29082","article-title":"EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection","volume":"136","author":"Giuliano","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.pvr.2016.05.001_bib39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males","volume":"364","author":"Giuliano","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.pvr.2016.05.001_bib40","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.pvr.2016.05.001_bib41","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1002\/jmv.22183","article-title":"Urine testing as a surveillance tool to monitor the impact of HPV immunization programs","volume":"83","author":"Cuschieri","year":"2011","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.pvr.2016.05.001_bib42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2147\/CLEP.S39799","article-title":"Monitoring human papillomavirus prevalence in urine samples: a review","volume":"5","author":"Enerly","year":"2013","journal-title":"Clin. Epidemiol."},{"issue":"8","key":"10.1016\/j.pvr.2016.05.001_bib43","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1086\/521629","article-title":"The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study","volume":"196","author":"Giuliano","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.pvr.2016.05.001_bib44","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jcv.2013.06.032","article-title":"Evaluation of genital self-sampling methods for HPV detection in males","volume":"58","author":"Hernandez","year":"2013","journal-title":"J. Clin. Virol."},{"issue":"1","key":"10.1016\/j.pvr.2016.05.001_bib45","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/infdis\/jiq015","article-title":"External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continents","volume":"203","author":"Vardas","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.pvr.2016.05.001_bib46","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1158\/1055-9965.EPI-08-0467","article-title":"Correlates of human papillomavirus viral load with infection site in asymptomatic men","volume":"17","author":"Flores","year":"2008","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"3","key":"10.1016\/j.pvr.2016.05.001_bib47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/sti.2008.033068","article-title":"Self-collection of genital human papillomavirus specimens in heterosexual men","volume":"85","author":"Ogilvie","year":"2009","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.pvr.2016.05.001_bib48","unstructured":"National Health and Nutrition Examination Survey (NHANES) Physician Examination Procedures Manual. Available at: \u3008http:\/\/www.cdc.gov\/nchs\/data\/nhanes\/nhanes_13_14\/Phys_Exam_Manual_2013.pdf\u3009, (accessed 31\/08\/15."},{"issue":"4","key":"10.1016\/j.pvr.2016.05.001_bib49","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/LGT.0000000000000118","article-title":"Gay and bisexual men\u2019s willingness to use a self-collected anal cancer screening test","volume":"19","author":"Thompson","year":"2015","journal-title":"J. Lower Genit. Tract Dis."},{"issue":"10","key":"10.1016\/j.pvr.2016.05.001_bib50","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/OLQ.0b013e318222899d","article-title":"Feasibility of incorporating self-collected rectal swabs into a community venue-based survey to measure the prevalence of HPV infection in men who have sex with men","volume":"38","author":"Gilbert","year":"2011","journal-title":"Sex. Transm. Dis."},{"issue":"8","key":"10.1016\/j.pvr.2016.05.001_bib51","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/OLQ.0b013e3181a44b8c","article-title":"High performance and acceptability of self-collected rectal swabs for diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in men who have sex with men and women","volume":"36","author":"van der Helm","year":"2009","journal-title":"Sex. Transm. Dis."},{"issue":"9","key":"10.1016\/j.pvr.2016.05.001_bib52","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.cmi.2015.05.038","article-title":"How to best measure the effectiveness of male human papillomavirus vaccine programmes?","volume":"21","author":"Garland","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"10.1016\/j.pvr.2016.05.001_bib53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/infdis\/jiu052","article-title":"One lesion, one virus: individual components of high-grade anal intraepithelial neoplasia in HIV-positive men contain a single HPV type","volume":"210","author":"Richel","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.pvr.2016.05.001_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.27989","article-title":"Incidence of potentially human papillomavirus\u2013related neoplasms in the United States, 1978 to 2007","volume":"119","author":"Kurdgelashvili","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.pvr.2016.05.001_bib55","unstructured":"E.S.M. Meites, G. Panicker, A. Zaidi, J. Braxton, R. Crosby, A. Parrish, T. Collins, B. Gratzer, J. Moore, P. Kerndt, P. Gorbach, E. Unger, L.E. Markowitz, Monitoring for HPV vaccine impact among Men who have Sex with Men \u2014 United States, 2012\u20132014, 30th International Papillomavirus (IPV) Conference; 17\u201321 September 2015, Lisbon, Portugal, 2015."},{"issue":"2","key":"10.1016\/j.pvr.2016.05.001_bib56","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.bjc.6605747","article-title":"Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England","volume":"103","author":"Howell-Jones","year":"2010","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.pvr.2016.05.001_bib57","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S1473-3099(14)70841-2","article-title":"Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study","volume":"14","author":"Tabrizi","year":"2014","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"10.1016\/j.pvr.2016.05.001_bib58","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/infdis\/jit192","article-title":"Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003\u20132010","volume":"208","author":"Markowitz","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.pvr.2016.05.001_bib59","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/sextrans-2011-050211","article-title":"Acceptability and response to a postal survey using self-taken samples for HPV vaccine impact monitoring","volume":"87","author":"Sinka","year":"2011","journal-title":"Sex. Transm. Infect."},{"issue":"9769","key":"10.1016\/j.pvr.2016.05.001_bib60","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0140-6736(10)62342-2","article-title":"Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study","volume":"377","author":"Giuliano","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.pvr.2016.05.001_bib61","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/infdis\/jiq021","article-title":"Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: the HPV in men (HIM) study","volume":"203","author":"Nyitray","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.pvr.2016.05.001_bib62","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jama.2012.101","article-title":"Prevalence of oral HPV infection in the United States, 2009\u20132010","volume":"307","author":"Gillison","year":"2012","journal-title":"JAMA"},{"issue":"9783","key":"10.1016\/j.pvr.2016.05.001_bib63","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(11)60551-5","article-title":"Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study","volume":"377","author":"Brotherton","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.pvr.2016.05.001_bib64","unstructured":"Cervical screening in Australia 2011\u20132012, Cancer Series No. 82 AIHW, Canberra Cat. no. CAN 79, 2014."},{"issue":"7","key":"10.1016\/j.pvr.2016.05.001_bib65","first-page":"915","article-title":"Incidence of cervical lesions in Danish women before and after implementation of a national HPV vaccination program","volume":"25","author":"Baldur-Felskov","year":"2014","journal-title":"Cancer Causes Control"},{"issue":"16","key":"10.1016\/j.pvr.2016.05.001_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.29266","article-title":"Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States","volume":"121","author":"Hariri","year":"2015","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.pvr.2016.05.001_bib67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/0284186X.2011.624545","article-title":"Quality assessment of the registration of vulvar and vaginal premalignant lesions at the Cancer Registry of Norway","volume":"51","author":"Enerly","year":"2012","journal-title":"Acta Oncol."},{"issue":"1","key":"10.1016\/j.pvr.2016.05.001_bib68","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1741-7015-11-227","article-title":"Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study","volume":"11","author":"Gertig","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.pvr.2016.05.001_bib69","doi-asserted-by":"crossref","first-page":"g1458","DOI":"10.1136\/bmj.g1458","article-title":"Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia","volume":"348","author":"Crowe","year":"2014","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.pvr.2016.05.001_bib70","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1200\/JCO.2013.52.4645","article-title":"Effectiveness of the quadrivalent human papillomavirus vaccine against cervical dysplasia in Manitoba, Canada","volume":"32","author":"Mahmud","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.pvr.2016.05.001_bib71","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.vaccine.2012.10.092","article-title":"Impact of human papillomavirus (HPV) vaccination on HPV 16\/18-related prevalence in precancerous cervical lesions","volume":"31","author":"Powell","year":"2012","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.pvr.2016.05.001_bib72","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/infdis\/jit361","article-title":"Declining genital warts in young women in England associated with HPV 16\/18 vaccination: an ecological study","volume":"208","author":"Howell-Jones","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.pvr.2016.05.001_bib73","doi-asserted-by":"crossref","first-page":"e105967","DOI":"10.1371\/journal.pone.0105967","article-title":"Decreased management of genital warts in young women in Australian general practice post introduction of National HPV Vaccination Program: results from a nationally representative cross-sectional general practice study","volume":"9","author":"Harrison","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.pvr.2016.05.001_bib74","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2105\/AJPH.2011.300465","article-title":"Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007\u20132010","volume":"102","author":"Bauer","year":"2012","journal-title":"Am. J. Public Health"},{"issue":"8","key":"10.1016\/j.pvr.2016.05.001_bib75","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.2105\/AJPH.2012.301182","article-title":"Prevalence of anogenital warts among participants in private health plans in the United States, 2003\u20132010: potential impact of human papillomavirus vaccination","volume":"103","author":"Flagg","year":"2013","journal-title":"Am. J. Public Health"},{"issue":"6","key":"10.1016\/j.pvr.2016.05.001_bib76","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/infdis\/jis405","article-title":"Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability","volume":"206","author":"Leval","year":"2012","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.pvr.2016.05.001_bib77","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2340\/00015555-1721","article-title":"A reduced national incidence of anogenital warts in young Danish men and women after introduction of a national quadrivalent human papillomavirus vaccination programme for young women--an ecological study","volume":"94","author":"Sando","year":"2014","journal-title":"Acta Derm.-Venereol."},{"issue":"6","key":"10.1016\/j.pvr.2016.05.001_bib78","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/jama.2014.95","article-title":"Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma","volume":"311","author":"Herweijer","year":"2014","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.pvr.2016.05.001_bib79","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1071\/SH09142","article-title":"Estimating the prevalence of and treatment patterns for juvenile onset recurrent respiratory papillomatosis in Australia pre-vaccination: a pilot study","volume":"7","author":"Novakovic","year":"2010","journal-title":"Sex. Health"},{"key":"10.1016\/j.pvr.2016.05.001_bib80","unstructured":"M. Deverell, Y.A. Zurynski, E.J. Elliott, Chief APSU study investigators, Australian Paediatric Surveillance Unit Annual Report. Australian Government, Department of Health. Available at: \u3008http:\/\/www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/cda-cdi3804k.htm\u3009, (accessed 31.08.15), 2014."}],"container-title":["Papillomavirus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405852115300197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405852115300197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T11:01:11Z","timestamp":1762513271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405852115300197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":80,"alternative-id":["S2405852115300197"],"URL":"https:\/\/doi.org\/10.1016\/j.pvr.2016.05.001","relation":{},"ISSN":["2405-8521"],"issn-type":[{"value":"2405-8521","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monitoring the impact of HPV vaccine in males\u2014Considerations and challenges","name":"articletitle","label":"Article Title"},{"value":"Papillomavirus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pvr.2016.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}